Schedule 13D ownership disclosure

ONCOCYTE CORPORATION

Security class unavailable · CUSIP: 68235C107

Event date: 2019-02-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
17.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-19-001036
Form type
SC 13D
Filer
BROADWOOD PARTNERS, L.P.
CIK
CIK 1278386
Filed
Feb 12, 2019
Reporting period
Feb 08, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub